Is Ascendis Pharma A/S halal to invest in?

As of July 2026, Ascendis Pharma A/S ASND is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Ascendis Pharma A/S a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ascendis Pharma A/S using these criteria to determine its compliance status.

Can Muslims buy shares of Ascendis Pharma A/S?

Muslim investors may consider investing in Ascendis Pharma A/S if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Ascendis Pharma A/S classified as HALAL?

Musaffa determines the Shariah status of Ascendis Pharma A/S by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Ascendis Pharma A/S updated?

The Shariah compliance status of Ascendis Pharma A/S may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Ascendis Pharma A/S become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Ascendis Pharma A/S?

You can check the latest Shariah compliance status of Ascendis Pharma A/S on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ASND Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Ascendis Pharma A/S is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

Ascendis Pharma A/S. Stock Analysis ASND

United States Health Care Large Cap Report: Q1, 2026

Ascendis Pharma A/S is a DK-based company operating in Biotechnology industry. Ascendis Pharma A/S is a Denmark‑based biopharmaceutical company operating within the life sciences and biotechnology sector. The firm scope of activity includes discovery, development, and commercialization of innovative therapies for rare diseases and serious chronic conditions with significant unmet medical needs where a clinically validated parent drug or pathway is suitable to company technologies. Ascendis Pharma A/S focuses on the endocrinology area and has a pipeline of three independent rare disease product candidates, such as Growth Hormone Deficiency (GHD), Hypoparathyroidism and Achondroplasia. The second therapeutic area is oncology, where the company focuses immunotherapy to targeted therapies.

Key Statistics of Ascendis Pharma A/S (ASND)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$252.51$257.71

Today's Open

$255.20

Volume

515.43K

P/E Ratio (TTM)

52 Week Range

$160.86$282.15

Market Cap

17.29B

Avg. Volume

877.01K

Dividend Yield

Financial Metrics & Statements of Ascendis Pharma A/S (ASND)

Super Investors Invested in Ascendis Pharma A/S (ASND)

FAQ's for Ascendis Pharma A/S (ASND)

As of July 2026, Ascendis Pharma A/S ASND is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ascendis Pharma A/S using these criteria to determine its compliance status.
Muslim investors may consider investing in Ascendis Pharma A/S if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Ascendis Pharma A/S by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Ascendis Pharma A/S may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Ascendis Pharma A/S on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.